home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

17.61 -0.05 (-0.28%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

19 20 Next >

Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday ↗

February 21, 2024

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.

Via Benzinga

Topics Stocks

Why NeoGenomics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

February 21, 2024

Shares of NeoGenomics, Inc. (NASDAQ: NEO) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY24 adjusted EPS...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 21, 2024

Via Benzinga

Evaluating NeoGenomics: Insights From 4 Financial Analysts ↗

February 21, 2024

Via Benzinga

Recap: NeoGenomics Q4 Earnings ↗

February 20, 2024

Via Benzinga

NeoGenomics's Earnings Outlook ↗

February 19, 2024

Via Benzinga

7 Analysts Have This To Say About NeoGenomics ↗

December 28, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

February 21, 2024

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 20, 2024

Via Benzinga

NeoGenomics Reports Fourth Quarter and Full Year 2023 Results

February 20, 2024

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics Signs Working with Cancer Pledge in Support of Employees

February 01, 2024

From NeoGenomics, Inc.

Via Business Wire

What 6 Analyst Ratings Have To Say About NeoGenomics ↗

November 07, 2023

Via Benzinga

Earnings Scheduled For February 20, 2024 ↗

February 20, 2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.

Via Benzinga

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

January 30, 2024

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

Via FinancialNewsMedia

NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024

January 30, 2024

From NeoGenomics, Inc.

Via Business Wire

Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle ↗

January 17, 2024

The company must pay $57 million in damages, but that's far less than expected.

Via Investor's Business Daily

Topics Intellectual Property

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

January 30, 2024

From FN Media Group LLC

Via GlobeNewswire

Bull of the Day - NeoGenomics ↗

January 12, 2024

But in late December, shares took a big hit on patent litigation with competitor Natera. Let's review the primary commercial business of NEO and then that will help put the legal news into context.

Via Talk Markets

Topics Intellectual Property

ROSEN, A LEADING NATIONAL FIRM, Encourages NeoGenomics, Inc. Investors to Inquire About Securities Class Action Investigation – NEO

January 02, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

January 02, 2024

From NeoGenomics, Inc.

Via Business Wire

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

December 29, 2023

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.

Via Benzinga

Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday ↗

December 29, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 28, 2023

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.

Via Benzinga

US Court Prohibits NeoGenomics To Sell Type Of Diagnostic Kits To Detect Smaller Number Of Cancer Cells, Favoring Natera In Lawsuit ↗

December 28, 2023

Shares of NeoGenomics Inc (NASDAQ: NEO) fell Thursday after the company received a preliminary injunction from a North Carolina district court, which prohibits the company from

Via Benzinga

Stocks Edge Higher As End Of 2023 Approaches ↗

December 28, 2023

The SPX is less than 10 points away from record close territory, and with one day left, all three major indexes are heading toward sizable December wins.

Via Talk Markets

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 28, 2023

Via Benzinga

NeoGenomics, Energy Fuels And Other Big Stocks Moving Lower On Thursday ↗

December 28, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 80 points on Thursday. Shares of NeoGenomics, Inc. (NASDAQ: NEO) shares fell sharply during Thursday’s session after Natera won a...

Via Benzinga

Topics Intellectual Property Lawsuit Stocks

NeoGenomics to Appeal Ruling

December 28, 2023

Via ACCESSWIRE

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response

December 05, 2023

Via ACCESSWIRE

NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference

November 14, 2023

Via ACCESSWIRE

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com